Vitamin E function and requirements in relation to PUFA

British Journal of Nutrition

Volumn 114, Issue 8, 2015, Pages 1113-1122

  Raederstorff, Daniel ^a   Wyss, Adrian ^a   Calder, Philip C ^b   Weber, Peter ^a   Eggersdorfer, Manfred ^a  

^a DSM NUTRITIONAL PRODUCTS LTD   (Switzerland)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

PUFA; Recommendations; Requirements; Vitamin E; Tocopherol

Indexed keywords

ALPHA TOCOPHEROL; LINOLEIC ACID; POLYUNSATURATED FATTY ACID; ANTIOXIDANT; EDIBLE OIL; UNSATURATED FATTY ACID;

CARDIOVASCULAR RISK; CELL MEMBRANE; CHEMICAL INTERACTION; CHEMICAL STRUCTURE; DIETARY REFERENCE INTAKE; FAT INTAKE; HEALTH STATUS; HUMAN; LIPID ANALYSIS; LIPID PEROXIDATION; LIPID VITAMIN INTERACTION; MEDICAL SOCIETY; MOLECULAR BIOLOGY; NONHUMAN; NUTRITIONAL ASSESSMENT; NUTRITIONAL REQUIREMENT; OXIDATIVE STRESS; REVIEW; VITAMIN FUNCTION; VITAMIN INTAKE; ANIMAL; DIET; DISEASE MODEL; DOSE RESPONSE; META ANALYSIS (TOPIC);

ANIMALS; ANTIOXIDANTS; DIET; DIETARY FATS, UNSATURATED; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS, UNSATURATED; HUMANS; META-ANALYSIS AS TOPIC; NUTRITIONAL REQUIREMENTS; VITAMIN E;

EID: 84944062810     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S000711451500272X     Document Type: Review

References (104)

1. Birben E, Sahiner UM, Sackesen C, et al. (2012) Oxidative stress and antioxidant defense. World Allergy Organ J 5, 9-19.
2. Niki E (2014) Role of vitamin E as a lipid-soluble peroxyl radical scavenger: in vitro and in vivo evidence. Free Radic Biol Med 66, 3-12.
3. Food and Nutrition Board IoM (2000) Dietary Reference Intake for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academies Press.
4. DACH DGfE, Österreichische gesellschaft für Ernährung, Schweizerische Gesellschaft für Ernährungsforschung, Schweizerische Vereinigung für Ernährung (2000) Referenzwerte für die Nährstoffzufuhr. Frankfurt am Main: DACH DGfE, Österreichische gesellschaft für Ernährung, Schweizerische Gesellschaft für Ernährungsforschung, Schweizerische Vereinigung für Ernährung.
5. Troesch B, Hoeft B, McBurney M, et al. (2012) Dietary surveys indicate vitamin intakes below recommendations are common in representative Western countries. Br J Nutr 108, 692-698.
6. Traber MG & Atkinson J (2007) Vitamin E, antioxidant and nothing more. Free Radic Biol Med 43, 4-15.
7. Traber MG & Stevens JF (2011) Vitamins C and E: beneficial effects from a mechanistic perspective. Free Radic Biol Med 51, 1000-1013.
8. Pfluger P, Kluth D, Landes N, et al. (2004) Vitamin E: underestimated as an antioxidant. Redox Rep 9, 249-254.
9. Brigelius-Flohe R (2006) Bioactivity of vitamin E. Nutr Res Rev 19, 174-186.
10. Cooney RV, Franke AA, Harwood PJ, et al. (1993) Gammatocopherol detoxification of nitrogen dioxide: superiority to alpha-Tocopherol. Proc Natl Acad Sci USA 90, 1771-1775.
11. Dillard CJ, Gavino VC & Tappel AL (1983) Relative antioxidant effectiveness of alpha-Tocopherol and gammatocopherol in iron-loaded rats. J Nutr 113, 2266-2273.
12. Grebenstein N, Schumacher M, Graeve L, et al. (2014) a-Tocopherol transfer protein is not required for the discrimination against ?-Tocopherol in vivo but protects it from side-chain degradation in vitro. Mol Nutr Food Res 58, 1052-1060.
13. Sontag TJ & Parker RS (2007) Influence of major structural features of tocopherols and tocotrienols on their omegaoxidation by tocopherol-omega-hydroxylase. J Lipid Res 48, 1090-1098.
14. Parker RS, Sontag TJ, Swanson JE, et al. (2004) Discovery, characterization, and significance of the cytochrome P450 omega-hydroxylase pathway of vitamin E catabolism. Ann NY Acad Sci 1031, 13-21.
15. Sontag TJ & Parker RS (2002) Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. J Biol Chem 277, 25290-25296.
16. Swanson JE, Ben RN, Burton GW, et al. (1999) Urinary excretion of 2,7, 8-Trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman is a major route of elimination of gammatocopherol in humans. J Lipid Res 40, 665-671.
17. Kramer JK, Fouchard RC & Kallury KM (1999) Determination of vitamin E forms in tissues and diets by high-performance liquid chromatography using normal-phase diol column. Methods Enzymol 299, 318-329.
18. Podda M, Weber C, Traber MG, et al. (1996) Simultaneous determination of tissue tocopherols, tocotrienols, ubiquinols, and ubiquinones. J Lipid Res 37, 893-901.
19. Serbinova EA & Packer L (1994) Antioxidant properties of alpha-Tocopherol and alpha-Tocotrienol. Methods Enzymol 234, 354-366.
20. Suzuki YJ, Tsuchiya M, Wassall SR, et al. (1993) Structural and dynamic membrane properties of alpha-Tocopherol and alpha-Tocotrienol: implication to the molecular mechanism of their antioxidant potency. Biochemistry 32, 10692-10699.
21. Yoshida Y, Niki E & Noguchi N (2003) Comparative study on the action of tocopherols and tocotrienols as antioxidant: chemical and physical effects. Chem Phys Lipids 123, 63-75.
22. Muller L, Theile K & Bohm V (2010) In vitro antioxidant activity of tocopherols and tocotrienols and comparison of vitamin E concentration and lipophilic antioxidant capacity in human plasma. Mol Nutr Food Res 54, 731-742.
23. Sookwong P, Nakagawa K, Yamaguchi Y, et al. (2010) Tocotrienol distribution in foods: estimation of daily tocotrienol intake of Japanese population. J Agric Food Chem 58, 3350-3355.
24. Burton GW, Joyce A & Ingold KU (1982) First proof that vitamin E is major lipid-soluble, chain-breaking antioxidant in human blood plasma. Lancet ii, 327.
25. Burton GW (1994) Vitamin E: molecular and biological function. Proc Nutr Soc 53, 251-262.
26. EFSA Panel on Dietetic Products NaAN (2010) Scientific opinion on the substantiation of health claims related to vitamin E and protection of DNA, proteins and lipids from oxidative damage. EFSA J 8, 1816.
27. Burton GW & Ingold KU (1989) Vitamin E as an in vitro and in vivo antioxidant. Ann NY Acad Sci 570, 7-22.
28. Traber MG (2014) Vitamin E inadequacy in humans: causes and consequences. Adv Nutr 5, 503-514.
29. Sokol RJ (1988) Vitamin E deficiency and neurologic disease. Annu Rev Nutr 8, 351-373.
30. Gohil K, Vasu VT & Cross CE (2010) Dietary alphatocopherol and neuromuscular health: search for optimal dose and molecular mechanisms continues! Mol Nutr Food Res 54, 693-709.
31. Shamim AA, Schulze K, Merrill RD, et al. (2015) Firsttrimester plasma tocopherols are associated with risk of miscarriage in rural Bangladesh. Am J Clin Nutr 101, 294-301.
32. Bjelakovic G, Nikolova D & Gluud C (2013) Meta-regression analyses, meta-Analyses, and trial sequential analyses of the effects of supplementation with beta-carotene, vitamin A, and vitamin E singly or in different combinations on all-cause mortality: do we have evidence for lack of harm? PLOS ONE 8, e74558.
33. Curtis AJ, Bullen M, Piccenna L, et al. (2014) Vitamin E supplementation and mortality in healthy people: a metaanalysis of randomised controlled trials. Cardiovasc Drugs Ther 28, 563-573.
34. Jiang S, Pan Z, Li H, et al. (2014) Meta-Analysis: low-dose intake of vitamin E combined with other vitamins or minerals may decrease all-cause mortality. J Nutr Sci Vitaminol (Tokyo) 60, 194-205.
35. Loffredo L, Perri L, Di Castelnuovo A, et al. (2015) Supplementation with vitamin E alone is associated with reduced myocardial infarction: a meta-Analysis. Nutr Metab Cardiovasc Dis 25, 354-363.
36. Gey KF, Puska P, Jordan P, et al. (1991) Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr 53, 326s-334s.
37. Gey KF (1993) Prospects for the prevention of free radical disease, regarding cancer and cardiovascular disease. Br Med Bull 49, 679-699.
38. Knekt P, Ritz J, Pereira MA, et al. (2004) Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. Am J Clin Nutr 80, 1508-1520.
39. Peter S, Moser U, Pilz S, et al. (2013) The challenge of setting appropriate intake recommendations for vitamin E: considerations on status and functionality to define nutrient requirements. Int J Vitam Nutr Res 83, 129-136.
40. Atkinson J, Harroun T, Wassall SR, et al. (2010) The location and behavior of alpha-Tocopherol in membranes. Mol Nutr Food Res 54, 641-651.
41. Atkinson J, Epand RF & Epand RM (2008) Tocopherols and tocotrienols in membranes: a critical review. Free Radic Biol Med 44, 739-764.
42. Marquardt D, Williams JA, Kucerka N, et al. (2013) Tocopherol activity correlates with its location in a membrane: a new perspective on the antioxidant vitamin E. J Am Chem Soc 135, 7523-7533.
43. Tanito M, Yoshida Y, Kaidzu S, et al. (2007) Acceleration of age-related changes in the retina in alpha-Tocopherol transfer protein null mice fed a vitamin E-deficient diet. Invest Ophthalmol Vis Sci 48, 396-404.
44. Lebold KM, Jump DB, Miller GW, et al. (2011) Vitamin E deficiency decreases long-chain PUFA in zebrafish (Danio rerio). J Nutr 141, 2113-2118.
45. Miller GW, Labut EM, Lebold KM, et al. (2012) Zebrafish (Danio rerio) fed vitamin E-deficient diets produce embryos with increased morphologic abnormalities and mortality. J Nutr Biochem 23, 478-486.
46. Lebold KM, Kirkwood JS, Taylor AW, et al. (2014) Novel liquid chromatography-mass spectrometry method shows that vitamin E deficiency depletes arachidonic and docosahexaenoic acids in zebrafish (Danio rerio) embryos. Redox Biol 2, 105-113.
47. Choi J, Leonard SW, Kasper K, et al. (2015) Novel function of vitamin E in regulation of zebrafish (Danio rerio) brain lysophospholipids discovered using lipidomics. J Lipid Res 56, 1182-1190.
48. Howard AC, McNeil AK & McNeil PL (2011) Promotion of plasma membrane repair by vitamin E. Nat Commun 2, article number 597.
49. Labazi M, McNeil AK, Kurtz T, et al. (2015) The antioxidant requirement for plasma membrane repair in skeletal muscle. Free Radic Biol Med 84, 246-253.
50. Mozaffarian D & Wu JH (2011) Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol 58, 2047-2067.
51. Kwak SM, Myung SK, Lee YJ, et al. (2012) Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-Analysis of randomized, double-blind, placebo-controlled trials. Arch Intern Med 172, 686-694.
52. Kotwal S, Jun M, Sullivan D, et al. (2012) Omega 3 fatty acids and cardiovascular outcomes: systematic review and metaanalysis. Circ Cardiovasc Qual Outcomes 5, 808-818.
53. Rizos EC, Ntzani EE, Bika E, et al. (2012) Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-Analysis. JAMA 308, 1024-1033.
54. Delgado-Lista J, Perez-Martinez P, Lopez-Miranda J, et al. (2012) Long chain omega-3 fatty acids and cardiovascular disease: a systematic review. Br J Nutr 107, Suppl. 2, S201-S213.
55. Wen YT, Dai JH & Gao Q (2014) Effects of Omega-3 fatty acid on major cardiovascular events and mortality in patients with coronary heart disease: a meta-Analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis 24, 470-475.
56. Miller PE, Van Elswyk M & Alexander DD (2014) Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-Analysis of randomized controlled trials. Am J Hypertens 27, 885-896.
57. von Schacky C (2015) Omega-3 fatty acids in cardiovascular disease-An uphill battle. Prostaglandins Leukot Essent Fatty Acids 92, 41-47.
58. Calder PC (2014) Very long chain omega-3 (n-3) fatty acids and human health. Eur J Lipid Sci Technol 116, 1280-1300.
59. DiNicolantonio JJ, Niazi AK, McCarty MF, et al. (2014) Omega-3s and cardiovascular health. Ochsner J 14, 399-412.
60. Mori TA (2014) Dietary n-3 PUFA and CVD: a review of the evidence. Proc Nutr Soc 73, 57-64.
61. Harris WS (2013) Are n-3 fatty acids still cardioprotective? Curr Opin Clin Nutr Metab Care 16, 141-149.
62. Skeaff CM & Miller J (2009) Dietary fat and coronary heart disease: summary of evidence from prospective cohort and randomised controlled trials. Ann Nutr Metab 55, 173-201.
63. Smith SC Jr, Benjamin EJ, Bonow RO, et al. (2011) AHA/ ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 124, 2458-2473.
64. Perk J, De Backer G, Gohlke H, et al. (2012) European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Atherosclerosis 223, 1-68.
65. Miller M, Stone NJ, Ballantyne C, et al. (2011) Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 123, 2292-2333.
66. Kris-Etherton PM & Innis S, American Dietician Association et al. (2007) Position of the American Dietetic Association and Dietitians of Canada: dietary fatty acids. J Am Diet Assoc 107, 1599-1611.
67. EFSA Panel on Dietetic Products Nutrition and Allergies (NDA) (2010) Scientific opinion on dietary reference values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. EFSA J 8(3), 1461.
68. Nodari S, Triggiani M, Campia U, et al. (2011) n-3 Polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study. Circulation 124, 1100-1106.
69. Nodari S, Triggiani M, Manerba A, et al. (2011) Effects of supplementation with polyunsaturated fatty acids in patients with heart failure. Intern Emerg Med 6, 37-44.
70. Moertl D, Hammer A, Steiner S, et al. (2011) Dose-dependent effects of omega-3-polyunsaturated fatty acids on systolic left ventricular function, endothelial function, and markers of inflammation in chronic heart failure of nonischemic origin: a double-blind, placebo-controlled, 3-Arm study. Am Heart J 161, 915.e911-919.
71. Miles EA & Calder PC (2012) Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis. Br J Nutr 107, Suppl. 2, S171-S184.
72. Koletzko B, Cetin I & Brenna JT (2007) Dietary fat intakes for pregnant and lactating women. Br J Nutr 98, 873-877.
73. Palmer DJ, Sullivan T, Gold MS, et al. (2012) Effect of n-3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ 344, e184.
74. Harvey N, Dhanwal D, Robinson S, et al. (2012) Does maternal long chain polyunsaturated fatty acid status in pregnancy influence the bone health of children? The Southampton Women's Survey. Osteoporos Int 23, 2359-2367.
75. Appleton KM, Rogers PJ & Ness AR (2010) Updated systematic review and meta-Analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. Am J Clin Nutr 91, 757-770.
76. Williams CD, Whitley BM, Hoyo C, et al. (2011) A high ratio of dietary n-6/n-3 polyunsaturated fatty acids is associated with increased risk of prostate cancer. Nutr Res 31, 1-8.
77. Patterson E, Wall R, Fitzgerald GF, et al. (2012) Health implications of high dietary omega-6 polyunsaturated fatty acids. J Nutr Metab 2012, 539426.
78. Harris PL & Embree ND (1963) Quantitative consideration of the effect of polyunsaturated fatty acid content of the diet upon the requirements for vitamin E. Am J Clin Nutr 13, 385-392.
79. Bieri JG & Poukka Evarts RH (1972) Vitamin E nutrition in the Rhesus monkey. Proc Soc Exp Biol Med 140, 1162-1165.
80. Witting LA & Horwitt MK (1964) Effect of degree of fatty acid unsaturation in tocopherol deficiency-induced creatinuria. J Nutr 82, 19-33.
81. Horwitt MK, Harvey CC, Duncan GD, et al. (1956) Effects of limited tocopherol intake in man with relationships to erythrocyte hemolysis and lipid oxidations. Am J Clin Nutr 4, 408-419.
82. Horwitt MK (1960) Vitamin E and lipid metabolism in man. Am J Clin Nutr 8, 451-461.
83. Horwitt MK (1974) Status of human requirements for vitamin E. Am J Clin Nutr 27, 1182-1193.
84. Horwitt MK (1986) Interpretations of requirements for thiamin, riboflavin, niacin-Tryptophan, and vitamin E plus comments on balance studies and vitamin B-6. Am J Clin Nutr 44, 973-985.
85. Valk EE & Hornstra G (2000) Relationship between vitamin E requirement and polyunsaturated fatty acid intake in man: a review. Int J Vitam Nutr Res 70, 31-42.
86. Bieri JG & Evarts RP (1973) Tocopherols and fatty acids in American diets. The recommended allowance for vitamin E. J Am Diet Assoc 62, 147-151.
87. Dayton S, Hashimoto S, Rosenblum D, et al. (1965) Vitamin E status of humans during prolonged feeding of unsaturated fats. J Lab Clin Med 65, 739-747.
88. Lewis JS & Alfin-Slater R (1969) An E/PUFA ratio of 0.4 maintains normal plasma tocopherol levels in growing children. Fed Proc 28, 758.
89. Witting LA & Lee L (1975) Dietary levels of vitamin E and polyunsaturated fatty acids and plasma vitamin E. Am J Clin Nutr 28, 571-576.
90. Allard JP, Kurian R, Aghdassi E, et al. (1997) Lipid peroxidation during n-3 fatty acid and vitamin E supplementation in humans. Lipids 32, 535-541.
91. Brown JE & Wahle KW (1990) Effect of fish-oil and vitamin E supplementation on lipid peroxidation and whole-blood aggregation in man. Clin Chim Acta 193, 147-156.
92. Wander RC, Du SH, Ketchum SO et al. (1996) Effects of interaction of RRR-Alpha-Tocopheryl acetate and fish oil on low-density-lipoprotein oxidation in postmenopausal women with and without hormone-replacement therapy. Am J Clin Nutr 63, 184-193.
93. Haglund O, Luostarinen R, Wallin R, et al. (1991) The effects of fish oil on triglycerides, cholesterol, fibrinogen and malondialdehyde in humans supplemented with vitamin E. J Nutr 121, 165-169.
94. Nair PP, Judd JT, Berlin E, et al. (1993) Dietary fish oil-induced changes in the distribution of alpha-Tocopherol, retinol, and beta-carotene in plasma, red blood cells, and platelets: modulation by vitamin E. Am J Clin Nutr 58, 98-102.
95. Julia C, Touvier M, Meunier N, et al. (2013) Intakes of PUFAs were inversely associated with plasma C-reactive protein 12 years later in a middle-Aged population with vitamin E intake as an effect modifier. J Nutr 143, 1760-1766.
96. Saboori S, Shab-Bidar S, Speakman JR, et al. (2015) Effect of vitamin E supplementation on serum C-reactive protein level: a meta-Analysis of randomized controlled trials. Eur J Clin Nutr 69, 867-873.
97. Guillot N, Caillet E, Laville M, et al. (2009) Increasing intakes of the long-chain omega-3 docosahexaenoic acid: effects on platelet functions and redox status in healthy men. FASEB J 23, 2909-2916.
98. Vericel E, Colas R, Calzada C, et al. (2015) Moderate oral supplementation with docosahexaenoic acid improves platelet function and oxidative stress in type 2 diabetic patients. Thromb Haemost 114, 283-296.
99. Muggli R (1994) Physiological requirements of vitamin E as a function of the amount and type of polyunsaturated fatty acid. World Rev Nutr Diet 75, 166-168.
100. Elmadfa I & Kornsteiner M (2009) Dietary fat intake-A global perspective. Ann Nutr Metab 54, Suppl. 1, 8-14.
101. Micha R, Khatibzadeh S, Shi P, et al. (2014) Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: a systematic analysis including 266 countryspecific nutrition surveys. BMJ 348, g2272.
102. Linseisen J, Schulze MB, Saadatian-Elahi M, et al. (2003) Quantity and quality of dietary fat, carbohydrate, and fiber intake in the German EPIC cohorts. Ann Nutr Metab 47, 37-46.
103. Witting LA (1974) Vitamin E-polyunsaturated lipid relationship in diet and tissues. Am J Clin Nutr 27, 952-959.
104. Witting LA (1972) Recommended dietary allowance for vitamin E. Am J Clin Nutr 25, 257-261.